Stock Price
14.89
Daily Change
-0.11 -0.73%
Monthly
10.26%
Yearly
34.71%
Q1 Forecast
14.47

Amarin reported $-1.7M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
AbbVie USD 5.72B 69M Jun/2025
Alnylam Pharmaceuticals USD -29.96M 34.85M Sep/2025
Amarin USD -1.7M 8.47M Sep/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
DBV Technologies USD -34.28M 6.83M Sep/2025
GlaxoSmithKline GBP 2.79B 716M Sep/2025
Halozyme Therapeutics USD 217.92M 15.48M Sep/2025
Ionis Pharmaceuticals USD -160.18M 304.96M Sep/2025
Neurocrine Biosciences USD 239.3M 93.7M Sep/2025
Novartis USD -9.19B 13.87B Jun/2025